1-Methyl-3-isobutylxanthine


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1080 CFTR Increases activity PMID:12914781
1385 CREB1 Increases activity PMID:29179997
154 ADRB2 Decreases expression PMID:24705868
1544 CYP1A2 Decreases activity PMID:11465391
1638 DCT Increases expression PMID:21972008
1675 CFD Increases expression PMID:9564879
2099 ESR1 Increases activity PMID:28711546
2167 FABP4 Increases expression PMID:22645054; PMID:9564879
3558 IL2 Decreases expression PMID:20711499
3559 IL2RA Decreases expression PMID:1709825
374 AREG Increases expression PMID:15284208
4023 LPL Increases expression PMID:22645054
4286 MITF Increases expression PMID:21972008; PMID:26748310
5142 PDE4B Increases expression PMID:20711499
5468 PPARG Increases expression PMID:22645054
5562 PRKAA1 Increases activity PMID:18390901
56729 RETN Increases expression PMID:22645054
5743 PTGS2 Increases expression PMID:15213229
6338 SCNN1B Increases expression PMID:20613715
7124 TNF Affects expression PMID:20711499; PMID:22645054
7299 TYR Increases activity PMID:26748310
7299 TYR Increases expression PMID:21972008; PMID:26748310; PMID:26748310
7306 TYRP1 Increases expression PMID:26748310
7857 SCG2 Decreases activity PMID:9473216
8654 PDE5A Increases expression PMID:20613715
9370 ADIPOQ Decreases expression PMID:22645054

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.